FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

704262001: Siltuximab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3010576017 Siltuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010669017 Siltuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4851561000005114 siltuximab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Siltuximab Is a monoklonalt antistof-agens false Inferred relationship Some
Siltuximab Is a Monoclonal antibody true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Siltuximab 100 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Siltuximab Inferred relationship Some
Product containing siltuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Some 1
Siltuximab 400 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Siltuximab Inferred relationship Some
Product containing only siltuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Some 1
Siltuximab 400 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1
Siltuximab 400 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Product containing only siltuximab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Some 1
Siltuximab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Siltuximab Inferred relationship Some 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Siltuximab Inferred relationship Some 1
Siltuximab 100 mg powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Siltuximab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start